To Ocugen CEO Shankar Musunuri, Ph.D., most gene therapy biotechs today lack vision. | Many gene therapy outfits focus on ...
Starting up in a garage isn’t an option for life sciences companies that do things like analyze microbes and test saliva samples. They need laboratory space, which is in short supply in Minnesota.
New Jersey's Johnson & Johnson grew from one ambitious pharmacist to a $94 billion pharmaceutical and medical device giant.
VCs and universities struggle with different goals and timelines, but tech transfer is helping turn academic science into ...
Takeda has pulled back from a research collaboration with a fellow Japanese life sciences company, ending work to discover ...
Houman Hemmati, a board-certified ophthalmologist, biotech executive and frequent Fox News guest, is a candidate to become ...
Biogen could see lower royalties for Ocrevus after its patent expires , but it has developed other medicines that will ...
In this edition of the biotech bi-weekly, get the latest biotech industry updates, with special focus on the upcoming AACR ...
Companies have long lamented Europe's fragmented capital markets, single-market adoption on pricing and clinical trials, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results